Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus

被引:80
作者
Kinoshita, A [1 ]
Whelan, CM [1 ]
Smith, CJ [1 ]
Berezovska, O [1 ]
Hyman, BT [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Alzheimer Unit,Alzheimer Dis Res Lab, Charlestown, MA 02129 USA
关键词
adapter protein; amyloid precursor protein; Fe65; FRET; gamma cleavage; intracellular domain;
D O I
10.1046/j.1471-4159.2002.01016.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid-beta, the peptide that deposits as senile plaques in Alzheimer's disease, is derived from the amyloid precursor protein (APP) by a gamma secretase-mediated intramembranous cleavage. In addition to amyloid-beta, this cleavage produces a carboxyl-terminal intracellular fragment which has an unknown function. The carboxyl-terminal domain of APP interacts in the cytoplasm with an adapter protein, Fe65. We demonstrate by laser scanning confocal microscopy that a gamma secretase generated APP carboxyl-terminal domain, tagged with green fluorescent protein (GFP), translocates to the nucleus in a manner dependent upon stabilization by the adapter protein Fe65; APP which has been mutated to block interactions with Fe65 cannot be detected in the nucleus. The APP-CT domain continues to interact with Fe65 in the nucleus, as determined by both colocalization and fluorescence resonance energy transfer (FRET). Visualization of the APP-CT-Fe65 complex in the nucleus may serve as a readout for processes that modify gamma secretase release of APP-CT.
引用
收藏
页码:839 / 847
页数:9
相关论文
共 35 条
[1]   NOTCH SIGNALING [J].
ARTAVANISTSAKONAS, S ;
MATSUNO, K ;
FORTINI, ME .
SCIENCE, 1995, 268 (5208) :225-232
[2]   Aspartate mutations in presenilin and γ-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservation of Notch1 signaling [J].
Berezovska, O ;
Jack, C ;
McLean, P ;
Aster, JC ;
Hicks, C ;
Xia, WM ;
Wolfe, MS ;
Kimberly, WT ;
Weinmaster, G ;
Selkoe, DJ ;
Hyman, BT .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (02) :583-593
[3]   Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent γ-secretase cleavage [J].
Berezovska, O ;
Jack, C ;
Deng, A ;
Gastineau, N ;
Rebeck, GW ;
Hyman, BT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30018-30023
[4]  
Borg JP, 1996, MOL CELL BIOL, V16, P6229
[5]   Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans [J].
Brown, MS ;
Ye, J ;
Rawson, RB ;
Goldstein, JL .
CELL, 2000, 100 (04) :391-398
[6]   A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60 [J].
Cao, XW ;
Südhof, TC .
SCIENCE, 2001, 293 (5527) :115-120
[7]   APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein [J].
Chow, NW ;
Korenberg, JR ;
Chen, XN ;
Neve, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11339-11346
[8]   The amyloid precursor protein (APP)-cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture [J].
Cupers, P ;
Orlans, I ;
Craessaerts, K ;
Annaert, W ;
De Strooper, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (05) :1168-1178
[9]   A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain [J].
De Strooper, B ;
Annaert, W ;
Cupers, P ;
Saftig, P ;
Craessaerts, K ;
Mumm, JS ;
Schroeter, EH ;
Schrijvers, V ;
Wolfe, MS ;
Ray, WJ ;
Goate, A ;
Kopan, R .
NATURE, 1999, 398 (6727) :518-522
[10]   Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain [J].
Dovey, HF ;
John, V ;
Anderson, JP ;
Chen, LZ ;
Andrieu, PD ;
Fang, LY ;
Freedman, SB ;
Folmer, B ;
Goldbach, E ;
Holsztynska, EJ ;
Hu, KL ;
Johnson-Wood, KL ;
Kennedy, SL ;
Kholedenko, D ;
Knops, JE ;
Latimer, LH ;
Lee, M ;
Liao, Z ;
Lieberburg, IM ;
Motter, RN ;
Mutter, LC ;
Nietz, J ;
Quinn, KP ;
Sacchi, KL ;
Seubert, PA ;
Shopp, GM ;
Thorsett, ED ;
Tung, JS ;
Wu, J ;
Yang, S ;
Yin, CT ;
Schenk, DB ;
May, PC ;
Altstiel, LD ;
Bender, MH ;
Boggs, LN ;
Britton, TC ;
Clemens, JC ;
Czilli, DL ;
Dieckman-McGinty, DK ;
Droste, JJ ;
Fuson, KS ;
Gitter, BD ;
Hyslop, PA ;
Johnstone, EM ;
Li, WY ;
Little, SP ;
Mabry, TE ;
Miller, FD ;
Ni, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :173-181